tiprankstipranks
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market

Avidity Biosciences (RNA) Stock Investors

300 Followers
Based on 728,786 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold RNA
On average, investors allocate 4.09% of their portfolios to RNA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RNA

2.1%
Last 7
Days
8.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RNA, out of 728,786 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RNA Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.46%
$14.54
Opened
0.00%
$12.14
Opened
0.97%
$21.46
Reduced
2.25%
$18.86
Based on the activity of 13,682 investors who made their portfolios public
The table shows changes in RNA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RNA Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Trade Desk
4.73%
-1.09%
-3.07%
39.18B
Technology
Merck & Company
4.12%
-0.11%
-0.79%
317.52B
Healthcare
DraftKings
7.19%
-0.88%
-3.40%
36.58B
Consumer Cyclical
Arista Networks
4.20%
-1.33%
-3.25%
81.06B
Technology
Micron
5.85%
+0.12%
+21.40%
128.82B
Technology
Riot Platforms
4.74%
-1.51%
-0.24%
2.02B
Financial
UiPath
3.53%
-0.55%
-2.02%
10.88B
Technology
ServiceNow
4.01%
-0.30%
-0.53%
150.97B
Technology
Marvell
4.86%
+1.33%
+6.29%
57.57B
Technology
Devon Energy
5.57%
-0.34%
-5.19%
32.81B
Energy
Based on the activity of 728,786 active portfolios
Open your Smart Portfolio

RNA Investor Analysis

RNA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.8%
of RNA holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
RNA investors between 35–55

Between 35–55

5.6%
Last 30 days
Holdings Change
54.9%
of RNA holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
RNA investors over 55

Over 55

15.5%
Last 30 days
Holdings Change
35.3%
of RNA holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of RNA stock investors
See who invests in RNA according to age group and performance.

FAQ

How many retail Investors hold RNA?
<0.1% of TipRanks' retail investors hold RNA in their portfolios.
    What is RNA Investor Sentiment?
    RNA’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of RNA in the last 7 days?
      ▼ 2.1% of TipRanks' retail investors changed their holding of RNA in the last 7 days.
        What percentage of retail investors changed their holding of RNA in the last 30 days?
        ▼ 8.4% of TipRanks' retail investors changed their holding of RNA in the last 30 days.
          What is the average age of retail investors who hold RNA?
          The average age of RNA Holders is between 35–55.
            What other stocks have RNA investors also bought?
            RNA Investors also bought TTD, MRK, DKNG, ANET, MU, RIOT, PATH, NOW, MRVL, DVN.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis